Compartir
Principles of Clinical Pharmacology (en Inglés)
Atkinson, Arthur J., Jr. (Edt)/ Huang, Shiew-Mei (Edt)/ Lertora, Juan J. L. (Edt)/ Markey, Sanford P. (Edt) (Autor)
·
Academic Press
· Tapa Dura
Principles of Clinical Pharmacology (en Inglés) - atkinson, arthur j., jr. (edt)/ huang, shiew-mei (edt)/ lertora, juan j. l. (edt)/ markey, sanford p. (edt)
$ 159.685
$ 199.606
Ahorras: $ 39.921
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Miércoles 17 de Julio y el
Lunes 29 de Julio.
Lo recibirás en cualquier lugar de Argentina entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Principles of Clinical Pharmacology (en Inglés)"
Principles of Clinical Pharmacology is a successful survey covering the pharmacologic principles underlying the individualization of patient therapy and contemporary drug development. This essential reference continues to focus on the basics of clinical pharmacology for the development, evaluation, and clinical use of pharmaceutical products while also addressing the most recent advances in the field. Written by leading experts in academia, industry, clinical and regulatory settings, the third edition has been thoroughly updated to provide readers with an ideal reference covering the wide range of important topics impacting clinical pharmacology as the discipline plays an increasingly significant role in drug development and regulatory science. The Third Edition has been endorsed by the American Society for Clinical Pharmacology and Therapeutics Includes new chapters on imaging and the pharmacogenetic basis of adverse drug reactionsOffers an expanded regulatory section that addresses US and international issues and guidelinesProvides extended coverage of earlier chapters on transporters, pharmacogenetics and biomarkers and also illustrates the impact of gender on drug responsePresents a broadened discussion of clinical trials from Phase 1 to incorporate Phases II and III